• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Determination of mutation patterns in human ornithine transcarbamylase precursor.

作者信息

Yan Shaomin, Wu Guang

机构信息

Guangxi Academy of Sciences, 98 Daling Road, Nanning, Guangxi Province, 530007, China.

出版信息

J Clin Monit Comput. 2009 Feb;23(1):51-7. doi: 10.1007/s10877-009-9162-3. Epub 2009 Feb 10.

DOI:10.1007/s10877-009-9162-3
PMID:19205909
Abstract

OBJECTIVE

The ornithine transcarbamylase is a mitochondrial matrix homotrimeric enzyme, whose deficiency is the most common genetic defect of the urea cycle and an X-linked semidominant disorder. To understand its mutation pattern is very helpful for managing its clinical manifest and outcome.

METHODS

The amino-acid pair predictability is used to transfer the symbolized human ornithine transcarbamylase and its 117 missense point mutants to scalar data and classify the amino-acid pairs as predictable and unpredictable in order that we can analyse the mutation pattern in scalar data domain rather than symbol domain.

RESULTS

The results show that the mutation is highly likely to occur at the unpredictable amino-acid pairs, and the mutation has the trend to make an amino-acid pair approach predictable.

CONCLUSION

The results provide insight on mutation from the viewpoint based on random mechanism.

摘要

相似文献

1
Determination of mutation patterns in human ornithine transcarbamylase precursor.
J Clin Monit Comput. 2009 Feb;23(1):51-7. doi: 10.1007/s10877-009-9162-3. Epub 2009 Feb 10.
2
The spfash mouse: a missense mutation in the ornithine transcarbamylase gene also causes aberrant mRNA splicing.spfash小鼠:鸟氨酸转氨甲酰酶基因中的错义突变也会导致异常的mRNA剪接。
Proc Natl Acad Sci U S A. 1989 Jun;86(11):4142-6. doi: 10.1073/pnas.86.11.4142.
3
The biochemical and molecular spectrum of ornithine transcarbamylase deficiency.鸟氨酸转氨甲酰酶缺乏症的生化与分子谱
J Inherit Metab Dis. 1998;21 Suppl 1:40-58. doi: 10.1023/a:1005353407220.
4
The molecular basis of ornithine transcarbamylase deficiency: modelling the human enzyme and the effects of mutations.鸟氨酸转氨甲酰酶缺乏症的分子基础:人类酶的建模及突变的影响
J Med Genet. 1995 Sep;32(9):680-8. doi: 10.1136/jmg.32.9.680.
5
Ten novel mutations of the ornithine transcarbamylase (OTC) gene in OTC deficiency.
Hum Mutat. 1998;Suppl 1:S5-7. doi: 10.1002/humu.1380110103.
6
[Molecular characterization of a new mutation E122G of human ornithine transcarbamylase gene].[人类鸟氨酸转氨甲酰酶基因新突变E122G的分子特征分析]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2003 Feb;20(1):19-22.
7
[Analysis of ornithine transcarbamylase gene mutations in three boys affected with late-onset ornithine transcarbamylase deficiency].[三名迟发性鸟氨酸转氨甲酰酶缺乏症男孩的鸟氨酸转氨甲酰酶基因突变分析]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2014 Oct;31(5):565-9. doi: 10.3760/cma.j.issn.1003-9406.2014.01.005.
8
Seven new mutations in the human ornithine transcarbamylase gene.人类鸟氨酸转氨甲酰酶基因中的七个新突变。
Hum Mutat. 1994;4(1):57-60. doi: 10.1002/humu.1380040109.
9
The primary structure of the imported mitochondrial protein, ornithine transcarbamylase from rat liver: mRNA levels during ontogeny.大鼠肝脏中导入的线粒体蛋白鸟氨酸转氨甲酰酶的一级结构:个体发育过程中的mRNA水平
DNA. 1985 Apr;4(2):147-56. doi: 10.1089/dna.1985.4.147.
10
A new mouse model of mild ornithine transcarbamylase deficiency (spf-j) displays cerebral amino acid perturbations at baseline and upon systemic immune activation.一种新的轻度鸟氨酸转氨甲酰酶缺乏症小鼠模型(spf-j)在基线时以及全身免疫激活后均表现出脑内氨基酸紊乱。
PLoS One. 2015 Feb 3;10(2):e0116594. doi: 10.1371/journal.pone.0116594. eCollection 2015.

本文引用的文献

1
Describing evolution of hemagglutinins from influenza A viruses using a differential equation.用微分方程描述甲型流感病毒血凝素的进化
Protein Pept Lett. 2009;16(7):794-804. doi: 10.2174/092986609788681751.
2
Three sampling strategies to predict mutations in H5N1 hemagglutitins from influenza A virus.预测甲型流感病毒H5N1血凝素突变的三种采样策略。
Protein Pept Lett. 2008;15(7):731-8. doi: 10.2174/092986608785133735.
3
The importance of making ends meet: mutations in genes and altered expression of proteins of the MRN complex and cancer.
收支平衡的重要性:MRN复合物的基因突变与蛋白质表达改变和癌症
Mutat Res. 2008 Sep-Oct;659(3):262-73. doi: 10.1016/j.mrrev.2008.05.005. Epub 2008 Jun 23.
4
Protein design by directed evolution.通过定向进化进行蛋白质设计。
Annu Rev Biophys. 2008;37:153-73. doi: 10.1146/annurev.biophys.37.032807.125832.
5
Cross-sectional multicenter study of patients with urea cycle disorders in the United States.美国尿素循环障碍患者的横断面多中心研究。
Mol Genet Metab. 2008 Aug;94(4):397-402. doi: 10.1016/j.ymgme.2008.05.004. Epub 2008 Jun 17.
6
Analysis of mRNA transcripts improves the success rate of molecular genetic testing in OTC deficiency.信使核糖核酸转录本分析提高了鸟氨酸转氨甲酰酶缺乏症分子基因检测的成功率。
Mol Genet Metab. 2008 Jul;94(3):292-7. doi: 10.1016/j.ymgme.2008.03.009. Epub 2008 Apr 25.
7
HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: a view from the clinic and ex vivo.HIV-1逆转录酶抑制剂耐药性突变与适应性:临床及体外研究视角
Virus Res. 2008 Jun;134(1-2):104-23. doi: 10.1016/j.virusres.2007.12.021. Epub 2008 Mar 4.
8
Advances in understanding molecular determinants in FeLV pathology.猫白血病病毒病理学中分子决定因素的理解进展。
Vet Immunol Immunopathol. 2008 May 15;123(1-2):14-22. doi: 10.1016/j.vetimm.2008.01.008. Epub 2008 Jan 19.
9
Prediction of mutations in H3N2 hemagglutinins of influenza A virus from North America based on different datasets.基于不同数据集对来自北美的甲型流感病毒H3N2血凝素突变进行预测。
Protein Pept Lett. 2008;15(2):144-52. doi: 10.2174/092986608783489571.
10
Mutation analysis of the ornithine transcarbamylase (OTC) gene in five Japanese OTC deficiency patients revealed two known and three novel mutations including a deep intronic mutation.对五名日本鸟氨酸转氨甲酰酶(OTC)缺乏症患者的OTC基因进行突变分析,发现了两个已知突变和三个新突变,其中包括一个内含子深处的突变。
Kobe J Med Sci. 2007;53(5):229-40.